ASPECT-2 study.
Lewis
Katherine A
KA
Carbajal
Enrique V
EV
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D003327:Coronary Disease / Q000517:prevention & control*; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000379:methods*
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors